PT1954264E - Processo para a preparação de intermediários de epoxibutanol - Google Patents

Processo para a preparação de intermediários de epoxibutanol Download PDF

Info

Publication number
PT1954264E
PT1954264E PT06804890T PT06804890T PT1954264E PT 1954264 E PT1954264 E PT 1954264E PT 06804890 T PT06804890 T PT 06804890T PT 06804890 T PT06804890 T PT 06804890T PT 1954264 E PT1954264 E PT 1954264E
Authority
PT
Portugal
Prior art keywords
manufacture
formula
epoxybutanol
intermediates
ethyl
Prior art date
Application number
PT06804890T
Other languages
English (en)
Portuguese (pt)
Inventor
Marc Muller
Lin Xu
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of PT1954264E publication Critical patent/PT1954264E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
PT06804890T 2005-12-01 2006-11-29 Processo para a preparação de intermediários de epoxibutanol PT1954264E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05026163 2005-12-01

Publications (1)

Publication Number Publication Date
PT1954264E true PT1954264E (pt) 2009-12-23

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06804890T PT1954264E (pt) 2005-12-01 2006-11-29 Processo para a preparação de intermediários de epoxibutanol

Country Status (19)

Country Link
US (2) US7816537B2 (https=)
EP (2) EP1954264B1 (https=)
JP (1) JP5329969B2 (https=)
KR (1) KR101191682B1 (https=)
CN (1) CN101321522B (https=)
AT (1) ATE444747T1 (https=)
AU (2) AU2006319657B2 (https=)
BR (1) BRPI0619120B1 (https=)
CA (2) CA2711852C (https=)
CY (1) CY1110588T1 (https=)
DE (1) DE602006009698D1 (https=)
DK (1) DK1954264T3 (https=)
ES (1) ES2333258T3 (https=)
HR (1) HRP20090675T1 (https=)
PL (1) PL1954264T3 (https=)
PT (1) PT1954264E (https=)
SI (1) SI1954264T1 (https=)
WO (1) WO2007062542A2 (https=)
ZA (1) ZA200804218B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI483950B (zh) 2009-09-21 2015-05-11 Gilead Sciences Inc 用於製備1’-取代碳核苷類似物之方法及中間物
BR122020020745B8 (pt) 2010-07-22 2023-10-31 Gilead Sciences Inc Composto antiviral para o tratamento de infecções por paramyxoviridae e composição farmacêutica que o compreende
HUE031679T2 (en) 2012-08-07 2017-07-28 Basilea Pharmaceutica Ag Process for the preparation of isavuconazole or ravuconazole
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI767201B (zh) 2014-10-29 2022-06-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
SI3349758T1 (sl) 2015-09-16 2022-08-31 Gilead Sciences, Inc. Postopki za zdravljenje okužb z virusom arenaviridae
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
US10682368B2 (en) 2017-03-14 2020-06-16 Gilead Sciences, Inc. Methods of treating feline coronavirus infections
AU2018262501B2 (en) 2017-05-01 2020-12-10 Gilead Sciences, Inc. Crystalline forms of (S) 2 ethylbutyl 2 (((S) (((2R,3S,4R,5R) 5 (4 aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
WO2019014247A1 (en) 2017-07-11 2019-01-17 Gilead Sciences, Inc. COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS
WO2019031240A1 (ja) 2017-08-10 2019-02-14 住友化学株式会社 エポキシアルコール化合物の製造方法
US11660307B2 (en) 2020-01-27 2023-05-30 Gilead Sciences, Inc. Methods for treating SARS CoV-2 infections
JP7554841B2 (ja) 2020-03-12 2024-09-20 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノヌクレオシドを調製する方法
WO2021207049A1 (en) 2020-04-06 2021-10-14 Gilead Sciences, Inc. Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
CA3179226A1 (en) 2020-05-29 2021-12-02 Tomas Cihlar Remdesivir treatment methods
AU2021296841B2 (en) 2020-06-24 2025-01-23 Gilead Sciences, Inc. 1'-cyano nucleoside analogs and uses thereof
SI4204421T1 (sl) 2020-08-27 2024-07-31 Gilead Sciences, Inc., Spojine in postopki za zdravljenje virusnih okužb
IL315102A (en) 2022-03-02 2024-10-01 Gilead Sciences Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
AU2931399A (en) 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
US6133485A (en) 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
US20110021794A1 (en) 2011-01-27
HRP20090675T1 (hr) 2010-01-31
JP2009517413A (ja) 2009-04-30
US7816537B2 (en) 2010-10-19
US8076494B2 (en) 2011-12-13
SI1954264T1 (sl) 2010-01-29
EP1954264A2 (en) 2008-08-13
DE602006009698D1 (de) 2009-11-19
BRPI0619120A2 (pt) 2011-09-13
WO2007062542A2 (en) 2007-06-07
BRPI0619120B1 (pt) 2023-10-10
PL1954264T3 (pl) 2010-02-26
CA2629092C (en) 2012-01-03
CN101321522A (zh) 2008-12-10
WO2007062542A3 (en) 2007-11-01
DK1954264T3 (da) 2010-01-11
EP2133345A1 (en) 2009-12-16
CA2629092A1 (en) 2007-06-07
KR20080075014A (ko) 2008-08-13
CA2711852C (en) 2011-10-04
CY1110588T1 (el) 2015-04-29
EP1954264B1 (en) 2009-10-07
AU2010203301B2 (en) 2012-06-21
AU2006319657A1 (en) 2007-06-07
ZA200804218B (en) 2009-01-28
US20090299073A1 (en) 2009-12-03
ES2333258T3 (es) 2010-02-18
CA2711852A1 (en) 2007-06-07
CN101321522B (zh) 2012-05-30
KR101191682B1 (ko) 2012-10-16
ATE444747T1 (de) 2009-10-15
JP5329969B2 (ja) 2013-10-30
AU2006319657B2 (en) 2010-08-12
AU2010203301A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
ZA200804218B (en) Process for the manufacture of epoxybutanol intermediates
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
PT2192109E (pt) Derivado de -aminoácido bicíclico
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
ATE372767T1 (de) Dpp-iv-hemmer
SE0202838D0 (sv) Chemical compounds
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
IL182396A0 (en) Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
DK1961734T3 (da) Aminforbindelse og anvendelse deraf til medicinske formål
IL159931A0 (en) Process for producing pyridine compound
UA96149C2 (en) Method for producing 4-oxoquinoline compound
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
NZ614088A (en) Process for preparing pyridinamines and novel polymorphs thereof
IL183805A0 (en) Process for preparing substituted thiophenesulfonyl isocyanates
AU2003289432A1 (en) Process for the production of 1-acetoxy-3-(substituted phenyl)propenes
SE0402734D0 (sv) Antimiicrobial compounds
DE602004028799D1 (en) Oligosaccharidderivat
EP1557407A4 (en) NEW ALPHA-CETOAMIDE DERIVATIVE AND USE THEREOF
TH80290A (th) อนุพันธ์เฟนิลพิเพอราซีนที่มีการรวมกันของพาร์เชียล โดพามีน-d2 รีเซพเตอร์แอกโกนิสซึมและการยับยั้งการดูดซึมเชอโรโทนินกลับ
EP1489076A4 (en) CYCLIC HEMIACETAL DERIVATIVE AND USE THEREOF